BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37466577)

  • 1. Incidence of and Risk Factors for Thromboembolism After Endoprosthetic Reconstruction in Musculoskeletal Oncology Patients.
    Sabharwal S; LiBrizzi CL; Forsberg JA; Morris CD; Levin AS;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):29-33. PubMed ID: 37466577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous tranexamic acid decreases intraoperative transfusion requirements and does not increase incidence of symptomatic venous thromboembolic events in musculoskeletal sarcoma surgery.
    Hess MC; Andrews NA; Crowley B; Singh NP; Howie C; McGwin G; Siegel H
    Surg Oncol; 2023 Oct; 50():101989. PubMed ID: 37717375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
    Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
    Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
    Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
    Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas.
    Mitchell SY; Lingard EA; Kesteven P; McCaskie AW; Gerrand CH
    J Bone Joint Surg Am; 2007 Nov; 89(11):2433-9. PubMed ID: 17974886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of venous thromboembolism in patients with primary sarcoma of bone.
    Kaiser CL; Freehan MK; Driscoll DA; Schwab JH; Bernstein KA; Lozano-Calderon SA
    Surg Oncol; 2017 Dec; 26(4):506-510. PubMed ID: 29113671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
    ; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
    JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
    Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.
    Haase DR; Templeton KJ; Rosenthal HG; Sweeney KR
    J Am Acad Orthop Surg; 2020 Mar; 28(6):248-255. PubMed ID: 32142488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence of Thromboembolic Events During Hospitalizations Following Surgical Resection of Lower Extremity Sarcomas in Children: Utilizing the Pediatric Health Information System Database.
    Wright J; Qamar F; McLaughlin M; Jodeh DS; Amankwah E; Mosha M; Halsey J; Binitie O; Metts J; Goldenberg N; Rottgers SA
    J Pediatr Orthop; 2023 Apr; 43(4):268-272. PubMed ID: 36693390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
    Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
    Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of symptomatic venous thromboembolism in oncologic patients undergoing lower-extremity endoprosthetic arthroplasty.
    Ramo BA; Griffin AM; Gill CS; McDonald DJ; Wunder JS; Ferguson P; Bell RS; Phillips SE; Schwartz HS; Holt GE
    J Bone Joint Surg Am; 2011 May; 93(9):847-54. PubMed ID: 21543674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Chang CH; Chang Y; Chen DW; Ueng SW; Lee MS
    Clin Orthop Relat Res; 2014 May; 472(5):1552-7. PubMed ID: 24385043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative thromboprophylaxis does not reduce the incidence of thromboembolic events after ACL reconstruction.
    Bayle-Iniguez X; Cassard X; Vinciguerra B; Murgier J
    Orthop Traumatol Surg Res; 2021 Jun; 107(4):102904. PubMed ID: 33789196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Tranexamic Acid in Implant-Based Breast Reconstruction Safely Reduces Hematoma without Thromboembolic Events.
    Weissler JM; Banuelos J; Jacobson SR; Manrique OJ; Nguyen MT; Harless CA; Tran NV; Martinez-Jorge J
    Plast Reconstr Surg; 2020 Aug; 146(2):238-245. PubMed ID: 32740567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    Topsoee MF; Bergholt T; Ravn P; Schouenborg L; Moeller C; Ottesen B; Settnes A
    Am J Obstet Gynecol; 2016 Jul; 215(1):72.e1-8. PubMed ID: 26829509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
    J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tourniquet use in patients undergoing tumour resection and endoprosthetic reconstruction of the knee.
    Gazendam AM; Schneider P; Vélez R; Ghert M;
    Bone Joint J; 2022 Oct; 104-B(10):1168-1173. PubMed ID: 36177639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.